Intas Biopharmaceuticals to purchase BPD
AHMEDABAD, India Poway, Calif.-based biotechnology company Biologists Process Development has a new owner.
Intas Biopharmaceuticals announced Friday that it was in the process of acquiring BPD for an undisclosed sum. Intas hopes the acquisition will expedite its entry into the U.S. market, particularly in the area of contract research and manufacturing services, also known as CRAMS.
Scott Brown will remain president and chief scientific officer of BPD, while Rajeev Datar will become the new chief executive officer.
“With Intas Biopharmaceuticals and BPD coming together, the two companies complement technical strengths of each other,” Datar said.
FDA requests delay on Merck application for cholesterol drugs
BOSTON The Food and Drug Administration has recommended that Merck wait until it finishes clinical trials of the cholesterol drugs MK-0524A and MK-0524B before re-filing a marketing application for them, Merck announced Friday.
The FDA rejected Merck’s application for the two drugs in April, and the FDA has advised that it should wait until it receives results from the clinical trial before re-filing.
MK-0524A is a combination of the drug Cordaptive and niacin; MK-0524B combines those ingredients with Zocor. Merck has said it does not plan to seek approval for MK-0524B until it completes the application for MK-0524A.
Adheris’ Glaser dies at 53
BURLINGTON, Mass. Matthew Glaser, 53, senior vice president of Professional Services for Adheris, passed away from cancer this past Saturday.
Glaser was a respected leader in the retail pharmacy industry who spent over 30 years working in community, chain, hospital and institutional pharmacy settings. Since 1996, he had dedicated his experience and skills to growing Adheris from a start-up to a leading provider of pharmacy-based patient education and adherence programs. At Adheris, he worked with chain and independent pharmacies, ensuring the delivery of appropriate compliance and adherence programs to their patients.
Prior to his tenure at Adheris, Glaser served as vice president of Pharmacy and Professional Affairs for Brooks Pharmacy, and as assistant vice president of Professional Services and vice president of Managed Care at Hook-SupeRx. Earlier in his career, he spent several years serving in various management positions at CVS.
Glaser held a Bachelor of Science degree in Pharmacy from Northeastern University.
Glaser is survived by his four children; his mother and several siblings and nieces and nephews. Memorial contributions may be made in his memory to the Matthew P. Glaser Memorial Scholarship Fund at the Massachusetts College of Pharmacy, Office of Advancement at 179 Longwood Ave., Boston, MA 02115.